Answers are grounded in this paper and cite their sources.
The broad relationship between the immune system and cancer is opening a new hallmark to explore for nanomedicine. Here, all the common and synergy points between both areas are reviewed and described, and the recent approaches which show the progress from the bench to the beside to biomarkers developed in nanomedicine and onco-immunotherapy.
No takes yet. Share an insight, caveat, or question.
Acebes-Fernández et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: